Striatal shape alteration as a staging biomarker for Parkinson’s Disease

Parkinson’s Disease provokes alterations of subcortical deep gray matter, leading to subtle changes in the shape of several subcortical structures even before the manifestation of motor and non-motor clinical symptoms. We used an automated registration and segmentation pipeline to measure this struc...

Full description

Bibliographic Details
Main Authors: Maxime Peralta, John S.H. Baxter, Ali R. Khan, Claire Haegelen, Pierre Jannin
Format: Article
Language:English
Published: Elsevier 2020-01-01
Series:NeuroImage: Clinical
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2213158220301091
id doaj-b33da8a300614d4bb1dc5adeeea4c171
record_format Article
spelling doaj-b33da8a300614d4bb1dc5adeeea4c1712020-11-25T04:01:39ZengElsevierNeuroImage: Clinical2213-15822020-01-0127102272Striatal shape alteration as a staging biomarker for Parkinson’s DiseaseMaxime Peralta0John S.H. Baxter1Ali R. Khan2Claire Haegelen3Pierre Jannin4INSERM, LTSI – UMR 1099, University of Rennes, Rennes, FranceINSERM, LTSI – UMR 1099, University of Rennes, Rennes, FranceImaging Research Laboratories, Robarts Research institute, Western University, London, CanadaINSERM, LTSI – UMR 1099, University of Rennes, Rennes, France; CHU Rennes, Rennes, FranceINSERM, LTSI – UMR 1099, University of Rennes, Rennes, France; Corresponding author.Parkinson’s Disease provokes alterations of subcortical deep gray matter, leading to subtle changes in the shape of several subcortical structures even before the manifestation of motor and non-motor clinical symptoms. We used an automated registration and segmentation pipeline to measure this structural alteration in one early and one advanced Parkinson’s Disease (PD) cohorts, one prodromal stage cohort and one healthy control cohort. These structural alterations are then passed to a machine learning pipeline to classify these populations. Our workflow is able to distinguish different stages of PD based solely on shape analysis of the bilateral caudate nucleus and putamen, with balanced accuracies in the range of 59% to 85%. Furthermore, we compared the significance of each of these subcortical structure, compared the performances of different classifiers on this task, thus quantifying the informativeness of striatal shape alteration as a staging bio-marker for PD.http://www.sciencedirect.com/science/article/pii/S2213158220301091Parkinson’s diseaseMorphometric biomarkersMachine learningStaging biomarkerMedical imaging
collection DOAJ
language English
format Article
sources DOAJ
author Maxime Peralta
John S.H. Baxter
Ali R. Khan
Claire Haegelen
Pierre Jannin
spellingShingle Maxime Peralta
John S.H. Baxter
Ali R. Khan
Claire Haegelen
Pierre Jannin
Striatal shape alteration as a staging biomarker for Parkinson’s Disease
NeuroImage: Clinical
Parkinson’s disease
Morphometric biomarkers
Machine learning
Staging biomarker
Medical imaging
author_facet Maxime Peralta
John S.H. Baxter
Ali R. Khan
Claire Haegelen
Pierre Jannin
author_sort Maxime Peralta
title Striatal shape alteration as a staging biomarker for Parkinson’s Disease
title_short Striatal shape alteration as a staging biomarker for Parkinson’s Disease
title_full Striatal shape alteration as a staging biomarker for Parkinson’s Disease
title_fullStr Striatal shape alteration as a staging biomarker for Parkinson’s Disease
title_full_unstemmed Striatal shape alteration as a staging biomarker for Parkinson’s Disease
title_sort striatal shape alteration as a staging biomarker for parkinson’s disease
publisher Elsevier
series NeuroImage: Clinical
issn 2213-1582
publishDate 2020-01-01
description Parkinson’s Disease provokes alterations of subcortical deep gray matter, leading to subtle changes in the shape of several subcortical structures even before the manifestation of motor and non-motor clinical symptoms. We used an automated registration and segmentation pipeline to measure this structural alteration in one early and one advanced Parkinson’s Disease (PD) cohorts, one prodromal stage cohort and one healthy control cohort. These structural alterations are then passed to a machine learning pipeline to classify these populations. Our workflow is able to distinguish different stages of PD based solely on shape analysis of the bilateral caudate nucleus and putamen, with balanced accuracies in the range of 59% to 85%. Furthermore, we compared the significance of each of these subcortical structure, compared the performances of different classifiers on this task, thus quantifying the informativeness of striatal shape alteration as a staging bio-marker for PD.
topic Parkinson’s disease
Morphometric biomarkers
Machine learning
Staging biomarker
Medical imaging
url http://www.sciencedirect.com/science/article/pii/S2213158220301091
work_keys_str_mv AT maximeperalta striatalshapealterationasastagingbiomarkerforparkinsonsdisease
AT johnshbaxter striatalshapealterationasastagingbiomarkerforparkinsonsdisease
AT alirkhan striatalshapealterationasastagingbiomarkerforparkinsonsdisease
AT clairehaegelen striatalshapealterationasastagingbiomarkerforparkinsonsdisease
AT pierrejannin striatalshapealterationasastagingbiomarkerforparkinsonsdisease
_version_ 1724445956537057280